154 related articles for article (PubMed ID: 12638729)
1. Beta-amyloid racemized at the Ser26 residue in the brains of patients with Alzheimer disease: implications in the pathogenesis of Alzheimer disease.
Kubo T; Kumagae Y; Miller CA; Kaneko I
J Neuropathol Exp Neurol; 2003 Mar; 62(3):248-59. PubMed ID: 12638729
[TBL] [Abstract][Full Text] [Related]
2. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.
Kaneko I; Morimoto K; Kubo T
Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586
[TBL] [Abstract][Full Text] [Related]
3. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients.
Kubo T; Nishimura S; Kumagae Y; Kaneko I
J Neurosci Res; 2002 Nov; 70(3):474-83. PubMed ID: 12391608
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of the amyloid β-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity.
Kumar S; Wirths O; Stüber K; Wunderlich P; Koch P; Theil S; Rezaei-Ghaleh N; Zweckstetter M; Bayer TA; Brüstle O; Thal DR; Walter J
Acta Neuropathol; 2016 Apr; 131(4):525-37. PubMed ID: 26898910
[TBL] [Abstract][Full Text] [Related]
5. [Neurotoxicity of beta-amyloid].
Kaneko I; Kubo T; Morimoto K
Nihon Yakurigaku Zasshi; 2000 Feb; 115(2):67-77. PubMed ID: 10876793
[TBL] [Abstract][Full Text] [Related]
6. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
7. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
10. N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits.
Tekirian TL; Saido TC; Markesbery WR; Russell MJ; Wekstein DR; Patel E; Geddes JW
J Neuropathol Exp Neurol; 1998 Jan; 57(1):76-94. PubMed ID: 9600199
[TBL] [Abstract][Full Text] [Related]
11. Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.
Owen JB; Sultana R; Aluise CD; Erickson MA; Price TO; Bu G; Banks WA; Butterfield DA
Free Radic Biol Med; 2010 Dec; 49(11):1798-803. PubMed ID: 20869432
[TBL] [Abstract][Full Text] [Related]
12. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
[TBL] [Abstract][Full Text] [Related]
13. Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration.
Wegiel J; Kuchna I; Nowicki K; Frackowiak J; Mazur-Kolecka B; Imaki H; Wegiel J; Mehta PD; Silverman WP; Reisberg B; Deleon M; Wisniewski T; Pirttilla T; Frey H; Lehtimäki T; Kivimäki T; Visser FE; Kamphorst W; Potempska A; Bolton D; Currie JR; Miller DL
Acta Neuropathol; 2007 Apr; 113(4):389-402. PubMed ID: 17237937
[TBL] [Abstract][Full Text] [Related]
14. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
Takahashi RH; Nagao T; Gouras GK
Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
[TBL] [Abstract][Full Text] [Related]
15. Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques.
Arai H; Lee VM; Otvos L; Greenberg BD; Lowery DE; Sharma SK; Schmidt ML; Trojanowski JQ
Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2249-53. PubMed ID: 1690426
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease.
Hoshi A; Yamamoto T; Shimizu K; Ugawa Y; Nishizawa M; Takahashi H; Kakita A
J Neuropathol Exp Neurol; 2012 Aug; 71(8):750-9. PubMed ID: 22805778
[TBL] [Abstract][Full Text] [Related]
17. Disruption of amyloid plaques integrity affects the soluble oligomers content from Alzheimer disease brains.
Jimenez S; Navarro V; Moyano J; Sanchez-Mico M; Torres M; Davila JC; Vizuete M; Gutierrez A; Vitorica J
PLoS One; 2014; 9(12):e114041. PubMed ID: 25485545
[TBL] [Abstract][Full Text] [Related]
18. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
[TBL] [Abstract][Full Text] [Related]
19. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
20. BetaAPP and furin mRNA concentrates in immature senile plaques in the brain of Alzheimer patients.
Marcinkiewicz M
J Neuropathol Exp Neurol; 2002 Sep; 61(9):815-29. PubMed ID: 12230328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
